BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder
NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ — Biohaven Ltd. (NYSE: BHVN) (“Biohaven”), a global clinical-stage biopharmaceutical company focused…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
High Growth Tech Stocks in Asia for October 2025
As trade tensions between the U.S. and China reignite, impacting global markets, Asian tech stocks continue to capture…
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
Opus Genetics, Inc. Robert Gagnon, CFO, Opus Genetics Robert Gagnon, CFO, Opus Genetics RESEARCH TRIANGLE PARK, N.C., Sept.…
Exploring High Growth Tech Stocks In The US Market
As the U.S. stock market navigates a period of volatility, with major indices like the Nasdaq retreating from…
3 Asian Stocks Estimated To Be Up To 40.9% Below Intrinsic Value
As trade negotiations between major economies progress, Asian markets have shown resilience, with Chinese and Japanese indices posting…
MacroGenics And 2 Other Promising Penny Stocks To Consider
Amid a backdrop of trade policy uncertainties and fluctuating market indices, the U.S. stock market remains near record…